BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 16684815)

  • 1. A complex interaction pattern of CIS and SOCS2 with the leptin receptor.
    Lavens D; Montoye T; Piessevaux J; Zabeau L; Vandekerckhove J; Gevaert K; Becker W; Eyckerman S; Tavernier J
    J Cell Sci; 2006 Jun; 119(Pt 11):2214-24. PubMed ID: 16684815
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of leptin signalling in hematopoietic cells using an adapted MAPPIT strategy.
    Montoye T; Piessevaux J; Lavens D; Wauman J; Catteeuw D; Vandekerckhove J; Lemmens I; Tavernier J
    FEBS Lett; 2006 May; 580(13):3301-7. PubMed ID: 16698021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mammalian protein-protein interaction trap (MAPPIT) analysis of STAT5, CIS, and SOCS2 interactions with the growth hormone receptor.
    Uyttendaele I; Lemmens I; Verhee A; De Smet AS; Vandekerckhove J; Lavens D; Peelman F; Tavernier J
    Mol Endocrinol; 2007 Nov; 21(11):2821-31. PubMed ID: 17666591
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional cross-modulation between SOCS proteins can stimulate cytokine signaling.
    Piessevaux J; Lavens D; Montoye T; Wauman J; Catteeuw D; Vandekerckhove J; Belsham D; Peelman F; Tavernier J
    J Biol Chem; 2006 Nov; 281(44):32953-66. PubMed ID: 16956890
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin receptor substrate 4 couples the leptin receptor to multiple signaling pathways.
    Wauman J; De Smet AS; Catteeuw D; Belsham D; Tavernier J
    Mol Endocrinol; 2008 Apr; 22(4):965-77. PubMed ID: 18165436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The C-terminus of CIS defines its interaction pattern.
    Lavens D; Ulrichts P; Catteeuw D; Gevaert K; Vandekerckhove J; Peelman F; Eyckerman S; Tavernier J
    Biochem J; 2007 Jan; 401(1):257-67. PubMed ID: 16961462
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of the Y985 and Y1077 motifs as SOCS3 recruitment sites in the murine leptin receptor.
    Eyckerman S; Broekaert D; Verhee A; Vandekerckhove J; Tavernier J
    FEBS Lett; 2000 Dec; 486(1):33-7. PubMed ID: 11108838
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Suppressor of cytokine signalling-2 controls hepatic gluconeogenesis and hyperglycemia by modulating JAK2/STAT5 signalling pathway.
    Zhang X; Zhuang Y; Qin T; Chang M; Ji X; Wang N; Zhang Z; Zhou H; Wang Q; Li JZ
    Metabolism; 2021 Sep; 122():154823. PubMed ID: 34197875
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOCS2 Inhibits Mitochondrial Fatty Acid Oxidation via Suppressing LepR/JAK2/AMPK Signaling Pathway in Mouse Adipocytes.
    Zhang T; Chen Y; Cai J; Pan M; Sun Q; Zhang J; Sun C
    Oxid Med Cell Longev; 2020; 2020():3742542. PubMed ID: 32733634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A systematic scan of interactions with tyrosine motifs in the erythropoietin receptor using a mammalian 2-hybrid approach.
    Montoye T; Lemmens I; Catteeuw D; Eyckerman S; Tavernier J
    Blood; 2005 Jun; 105(11):4264-71. PubMed ID: 15644415
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The SOCS2 ubiquitin ligase complex regulates growth hormone receptor levels.
    Vesterlund M; Zadjali F; Persson T; Nielsen ML; Kessler BM; Norstedt G; Flores-Morales A
    PLoS One; 2011; 6(9):e25358. PubMed ID: 21980433
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effect of suppressor of cytokine signaling 2 (SOCS2) on fat metabolism induced by growth hormone (GH) in porcine primary adipocyte.
    Yang HL; Sun C; Sun C; Qi RL
    Mol Biol Rep; 2012 Sep; 39(9):9113-22. PubMed ID: 22729878
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Suppressor of cytokine signaling (SOCS) proteins are induced by IL-7 and target surface CD127 protein for degradation in human CD8 T cells.
    Ghazawi FM; Faller EM; Parmar P; El-Salfiti A; MacPherson PA
    Cell Immunol; 2016; 306-307():41-52. PubMed ID: 27423467
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Regulation of cytokine-inducible SH2-containing protein (CIS) by ubiquitination and Elongin B/C interaction.
    Jensik PJ; Arbogast LA
    Mol Cell Endocrinol; 2015 Feb; 401():130-41. PubMed ID: 25448846
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct activities of suppressor of cytokine signaling (SOCS) proteins and involvement of the SOCS box in controlling G-CSF signaling.
    van de Geijn GJ; Gits J; Touw IP
    J Leukoc Biol; 2004 Jul; 76(1):237-44. PubMed ID: 15107455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential roles of SOCS family members in EpoR signal transduction.
    Jegalian AG; Wu H
    J Interferon Cytokine Res; 2002 Aug; 22(8):853-60. PubMed ID: 12396724
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PRL receptor-mediated effects in female mouse adipocytes: PRL induces suppressors of cytokine signaling expression and suppresses insulin-induced leptin production in adipocytes in vitro.
    Ling C; Billig H
    Endocrinology; 2001 Nov; 142(11):4880-90. PubMed ID: 11606456
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Suppressor of cytokine signalling-2 limits IGF1R-mediated regulation of epithelial-mesenchymal transition in lung adenocarcinoma.
    Zhou Y; Zhang Z; Wang N; Chen J; Zhang X; Guo M; John Zhong L; Wang Q
    Cell Death Dis; 2018 Apr; 9(4):429. PubMed ID: 29559623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppressor of cytokine signaling 7 inhibits prolactin, growth hormone, and leptin signaling by interacting with STAT5 or STAT3 and attenuating their nuclear translocation.
    Martens N; Uzan G; Wery M; Hooghe R; Hooghe-Peters EL; Gertler A
    J Biol Chem; 2005 Apr; 280(14):13817-23. PubMed ID: 15677474
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Suppressor of cytokine signaling 1 interacts with oncogenic lymphocyte-specific protein tyrosine kinase.
    Venkitachalam S; Chueh FY; Leong KF; Pabich S; Yu CL
    Oncol Rep; 2011 Mar; 25(3):677-83. PubMed ID: 21234523
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.